The oncogene of BAV-3 as a mutagen.
We studied the mutagenic and carcinogenic effects on mammalian cells of two EcoRI DNA fragments of bovine adenovirus type3 (BAV-3) integrated into the pBR325 plasmid. Fragment D located between 3.6 and 19.7 map units, contains the viral oncogene, fragment C, located between 44.3 and 63.7 map units, has no oncogenic activity. The BAV-3 oncogene was shown to increase significantly the frequency of 6-mercaptopurine (6MP)-resistant mutants in Chinese hamster calls. Fragment C, pBR325 without viral sequences and DNA from normal Syrian hamster cells did not have any mutagenic effect. We also looked at the combined action of the viral DNA fragments and the tumour promoter 12-O-tetradecanoylphorbol-13-acetate (TPA), which enhances the transforming effect of carcinogens. TPA was shown to increase the mutant yield on exposure to the viral oncogene but not to induce mutagenic activity in those types of DNA that are unable to transform cells. Probably TPA does not affect the initiation of the mutation process, but acts on later stages just as it affects carcinogenic activity. Thus the results obtained confirm the existence of parallelism between the mutagenic and transforming effects of viral DNA and show that both activities are mapped in the same region of viral DNA - its oncogene.
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D002417:Cattle; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D006224:Cricetinae; D003412:Cricetulus; D004262:DNA Restriction Enzymes / Q000235:genetics; D004279:DNA, Viral / Q000235:genetics*; D015246:Deoxyribonuclease EcoRI; D004351:Drug Resistance; D015122:Mercaptopurine; D008647:Mesocricetus; D009154:Mutation; D009857:Oncogenes; D010957:Plasmids; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D004279:DNA, Viral; D015122:Mercaptopurine; D004262:DNA Restriction Enzymes; D015246:Deoxyribonuclease EcoRI; D013755:Tetradecanoylphorbol Acetate